Common Contracts
2 similar Development and Supply Agreement contracts by Impax Laboratories Inc
DISTRIBUTION, LICENSE, DEVELOPMENT AND SUPPLY AGREEMENT between ASTRAZENECA UK LIMITED and Impax LABORATORIES, INC. Dated as of January 31, 2012Development and Supply Agreement • April 2nd, 2012 • Impax Laboratories Inc • Pharmaceutical preparations • Delaware
This Distribution, License, Development and Supply Agreement (the “Agreement”) is made and entered into effective as of January 31, 2012 (the “Effective Date”) by and between AstraZeneca UK Limited, a company incorporated in England under no. 3674842 whose registered office is at 2 Kingdom Street, London, W2 6BD, England (“AstraZeneca”), and Impax Laboratories, Inc., a Delaware corporation located at 30831 Huntwood Avenue, Hayward, CA 94544 (“Impax”). AstraZeneca and Impax are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
DISTRIBUTION, LICENSE, DEVELOPMENT AND SUPPLY AGREEMENT between ASTRAZENECA UK LIMITED and Impax LABORATORIES, INC. Dated as of January 31, 2012Development and Supply Agreement • February 6th, 2012 • Impax Laboratories Inc • Pharmaceutical preparations • Delaware
This Distribution, License, Development and Supply Agreement (the “Agreement”) is made and entered into effective as of January 31, 2012 (the “Effective Date”) by and between AstraZeneca UK Limited, a company incorporated in England under no. 3674842 whose registered office is at 2 Kingdom Street, London, W2 6BD, England (“AstraZeneca”), and Impax Laboratories, Inc., a Delaware corporation located at 30831 Huntwood Avenue, Hayward, CA 94544 (“Impax”). AstraZeneca and Impax are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
